Whalesbook
KIMS Hospitals: Expansion Drives Revenue Surge, Squeezes Profitability in Q3 FY26
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has announced its Q3 FY26 unaudited consolidated financial results, showcasing impressive top-line expansion alongside significant pressure on profitability. The company successfully crossed the INR 1,000 Crore mark in quarterly revenue, a testament to its aggressive growth strategy.
📉 The Financial Deep Dive
The Numbers:
For the third quarter ended December 31, 2025 (Q3 FY26), KIMS Hospitals reported consolidated revenue from operations at INR 998 Cr, marking a substantial 29.2% increase year-on-year (YoY) and 3.9% quarter-on-quarter (QoQ). Total consolidated revenue stood at INR 1003 Cr, a 26.9% YoY and 3.9% QoQ growth.
However, profitability metrics painted a challenging picture. Consolidated EBITDA (Pre-INDAS) declined 2.2% YoY to INR 193 Cr. Excluding other income, consolidated EBITDA grew a marginal 4.6% YoY to INR 188 Cr, but declined 4.3% QoQ.
The most significant concern is the EBITDA margin compression, which fell sharply to 20.4% in Q3 FY26 from 25.9% in Q3 FY25 and 21.6% in Q2 FY26. This nearly 540 basis point drop YoY underscores the cost pressures.
Consequently, Profit After Tax (PAT) saw a steep decline of 43.6% YoY to INR 52 Cr (from INR 93 Cr in Q3 FY25). Consolidated Earnings Per Share (EPS) mirrored this trend, falling 39.9% YoY to INR 1.3.
The Quality:
The strong revenue growth was underpinned by improvements in key operational metrics. Average Revenue Per Occupied Bed (ARPOB) rose 20.5% YoY and 10.3% QoQ, while Average Revenue Per Patient (ARPP) increased 13.9% YoY and 9.0% QoQ. Despite these positive volume and realization drivers, the cost associated with newly commenced hospital units significantly impacted the bottom line. Increased depreciation and finance costs, alongside operational expenses from new facilities, diluted profitability.
The Management Commentary:
Dr. B Bhaskar Rao, CMD of KIMS Hospitals, highlighted increasing patient footfalls across all centers, particularly noting the steady ramp-up of the Bangalore and Thane units. He expressed optimism for a "healthy closure to FY 26,” indicating confidence in future performance. While specific future guidance was not provided, the management's focus is on the continued operational integration and optimization of these newer hospitals.
🚩 Risks & Outlook
The primary risk for KIMS Hospitals remains the profitability impact from its ongoing expansion phase. The significant margin compression indicates that the cost of setting up and operating new facilities is currently outweighing their revenue generation, leading to reduced PAT and EPS. Investors will need to closely monitor the pace at which these new units achieve operational efficiency and contribute positively to margins. The company's ability to leverage its specialized medical expertise, evidenced by numerous complex clinical achievements reported, will be crucial in driving sustainable, profitable growth. The short-to-medium term outlook hinges on managing ramp-up costs effectively while capitalizing on increasing patient footfalls and the growing demand for advanced healthcare services.